ServiceNow Stock Has Worst Day Ever on Disappointing Sales

ServiceNow shares plunged almost 18% after results disappointed investors, despite subscription revenue rising 22% to $3.67 billion in line with estimates. The company said delayed closings of several large Middle East on-premise deals due to the ongoing conflict trimmed growth by roughly 1 percentage point, while June subscription revenue is guided to $3.82 billion versus $3.75 billion expected. Management also raised full-year AI annual contract value to $1.5 billion from $1 billion, and the recent $7.75 billion Armis acquisition will add about 1.25 points to growth but compress margins by about 0.75 points.

Analysis

The market is treating this as more than a one-quarter miss: the bigger issue is that NOW is being repriced from a “durable compounder” into a software vendor with visible deal-cycle fragility and a less certain AI monetization path. The Middle East delay is probably not the earnings driver by itself; the second-order hit is to booking quality, because large on-premise deals are exactly where investors assume more discretionary urgency and less churn risk. That means any normalization in geopolitics may restore revenue timing, but not necessarily the multiple unless management can show that pipeline conversion and enterprise budget scrutiny are holding up elsewhere.

The AI annual contract value raise is directionally positive, but in this tape it is more a defensive narrative than a near-term valuation bridge. Investors are increasingly asking whether AI features expand wallet share or simply defend seat count; if customers are still pausing core transformations, AI attach alone won’t offset slower large-deal closes. That creates a medium-term asymmetry: the company can hit headline growth, yet still face multiple compression if management is forced to keep spending into a demand slowdown.

For competitors, the read-through is mixed. CRM and WDAY get a relative sentiment lift only if investors believe NOW-specific execution is the problem; if the concern is broader enterprise deal elongation, then the whole high-multiple workflow software cohort remains vulnerable on any weak macro datapoint. IBM’s in-line software print suggests this is not just one company issue — buyers are increasingly selective, so the winners will be vendors with faster payback and clearer cost takeout, not the broad “AI platform” stories.

The contrarian point: the selloff may be overdone tactically if the market is extrapolating one geopolitically delayed quarter into a secular demand break. But the stock is unlikely to recover meaningfully until management proves that the Armis acquisition is accretive to growth quality rather than just a revenue plug, and that AI ACV is translating into measurable expansion rather than marketing headline noise. Near term, that keeps the burden of proof firmly on the company for the next 1-2 quarters.

Key Decisions for Investors

• Short NOW on a 2-6 week horizon into any bounce; the setup favors continued multiple compression until management demonstrates deal reacceleration. Risk/reward is attractive if the stock retraces only part of the post-earnings gap, with a stop above the preprint breakdown zone.
• Pair trade: long CRM / short NOW for 1-3 months. The relative thesis is that CRM’s broader installed base and less exposed near-term deal timing should make it a cleaner shelter if enterprise software sentiment remains weak.
• Buy short-dated put spreads on WDAY or a software basket ETF as a hedge against broader enterprise spending disappointment. This is a lower-cost way to express that the issue may be cohort-wide rather than idiosyncratic.
• Do not chase the post-print move in IBM as a defensive long in software until the next data point confirms that in-line is good enough for re-rating; use any strength to rotate into higher-quality cash-generative software with clearer pricing power.
• Set a 1-2 quarter catalyst watch on NOW for evidence that AI ACV is converting into net-new large deal wins; if not, reassess for a longer-duration underweight because the multiple may have to reset to a slower-growth profile.